A phase 2, randomized, double-blind, placebo-controlled study of ubenimex in patients with pulmonary arterial hypertension (WHO Group 1) (LIBERTY)
Clinical Trial Grant
Administered By
Medicine, Cardiology
Awarded By
Eiger BioPharmaceuticals, Inc.
Start Date
June 1, 2016
End Date
December 31, 2018
Administered By
Medicine, Cardiology
Awarded By
Eiger BioPharmaceuticals, Inc.
Start Date
June 1, 2016
End Date
December 31, 2018